Learning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels.

These considerations highlight the important role that pharmacoepidemiologists and drug safety professionals must play within the monitoring and use of these tools. Furthermore, these issues highlight the guiding role that regulators need to have in planning and oversight of these tools.